Org.nr 998 036 011 2011 → 2012 Year-over-year analysis

4 HEALTH INNOVATION NORGE AS: årsregnskap 2012 vs 2011

Mixed movements in the accounts

approved 2013-05-29; registry 2013-08-17; journal 2013 641389

Full company analysis · All year comparisons

What changed

Comparing Årsregnskap 2012 with 2011 for 4 HEALTH INNOVATION NORGE AS. Revenue 0 NOK → 0 NOK (0.0%). Equity 22.0k NOK → -52.9k NOK.

Pressures included: equity eroded; current ratio dropped below 1×.

Also worth watching: thin equity buffer. All figures are taken from the published annual accounts for 4 HEALTH INNOVATION NORGE AS.

Scorecard

Revenue
0 NOK 0 NOK
0.0%
Equity
22.0k NOK -52.9k NOK
-340.7%
Cash
0 NOK 0 NOK
0.0%
Total assets
30.0k NOK 34.4k NOK
+14.5%

What deteriorated

  • ↓

    Equity eroded

    Book equity 22.0k NOK → -52.9k NOK (equity ratio 73.3% → -154.1%). Calculated

  • ↓

    Current ratio dropped below 1×

    Current ratio 3.75× → 0.02× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated

Things to notice

  • ·

    Thin equity buffer

    Equity ratio is -154.1% of assets — limited loss-absorbing capacity on a stand-alone basis. Interpretation